Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Deficit)

v3.21.1
Condensed Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ (4,490,016) $ 8,181 $ 7,685,533 $ (12,183,730)
Beginning balance, Shares at Dec. 31, 2019   8,180,937    
Stock-based compensation expense 139,758   139,758  
Warrant expense/ Issuance of warrants 190,993   190,993  
Issuance of common stock 4,871 $ 1 4,870  
Issuance of common stock, Shares   874    
Net loss (547,440)     (547,440)
Ending balance at Mar. 31, 2020 (4,701,834) $ 8,182 8,021,154 (12,731,170)
Ending balance, Shares at Mar. 31, 2020   8,181,811    
Beginning balance at Dec. 31, 2020 $ 9,784,356 $ 10,051 24,805,929 (15,031,624)
Beginning balance, Shares at Dec. 31, 2020 10,050,849 10,050,849    
Stock-based compensation expense $ 591,124   591,124  
Warrant expense/ Issuance of warrants 237,768   237,768  
Issuance of common stock 60,391 $ 9 60,382  
Issuance of common stock, Shares   9,000    
Net loss (2,637,068)     (2,637,068)
Ending balance at Mar. 31, 2021 $ 8,036,571 $ 10,060 $ 25,695,203 $ (17,668,692)
Ending balance, Shares at Mar. 31, 2021 10,059,849 10,059,849